http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-005313-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c22c6d06e5563aee18cc3c610cfa6180
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24234
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-645
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2730-10134
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G83-003
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-646
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-292
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G83-00
filingDate 2001-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3519964771e88f4bea25920a16adb058
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9ca7564386b79cc99d5293e6d1fe34d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47aaabde55a634159d1b09c8cbfe7250
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6984cdfc3914a4369d7779a2bd6cc53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fdd7ca58479cd0d45823d5a69ff13b22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4c45af64b6b4734a4ba51e00f785df4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a902ce997c79d580780308d195018df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cf5b0a271651e6fe7f60e0b7fd24da8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9fcd3b19f7baaa32899fa92b70b07bc
publicationDate 2004-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-005313-B1
titleOfInvention METHOD FOR OBTAINING ANTIGENAL STRUCTURES STRENGTHENING SPECIFIC CROSS-REACTIVITY
abstract The present invention relates to a method for producing antigenic structures with high cross-reactivity capable of enhancing the immune response to peptide antigens that are intended for systemic administration and / or administration through the mucous membrane, as well as chemical structures obtained by this method, preparations based on these structures and their application. The method described in the present invention, allows to obtain new antigenic structures, starting with the selection and synthesis of branched structures that bind to carrier molecules. The resulting structures can be used together with acceptable adjuvants or in the composition of various antigens. Synergistic effects may be observed, enhancing cross-reactivity and immunogenicity. In addition, these drugs may contain stabilizers and preservatives. Antigenic structures of the present invention can be used in the pharmaceutical industry in the form of vaccine preparations for the prevention or treatment of diseases in humans and animals, as well as for the creation of diagnostic systems.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016114676-A1
priorityDate 2000-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID11676
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID12721
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16131185
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID573621
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID487
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID11709
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419584876
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID11676
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID12637
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7922
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5960
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10407
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP04958
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485535
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422600897
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3485
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID11103
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID487
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID743
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6227
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID12721
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416017452
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10407
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID12637
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520590
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID11709
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474136
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419539584
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID11103
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410068132

Total number of triples: 85.